[Efficacy and safety of cetuximab+irinotecan for unresectable advanced or recurrent colorectal cancer].
Soda H, Nemoto H, Akatsuka S, Arioka H, Shimada K, Ito T, Takinishi Y, Egawa M, Nagashima A, Kenmochi T, Sasaki T, Azuma T, Koizumi W, Hibi K.
Soda H, et al. Among authors: koizumi w.
Gan To Kagaku Ryoho. 2013 May;40(5):605-8.
Gan To Kagaku Ryoho. 2013.
PMID: 23863582
Japanese.